(HealthDay News) — The novel herpes simplex virus (HSV) helicase-primase inhibitor pritelivir is more effective than valacyclovir for reducing genital HSV-2 shedding, according to a study published in ...

New research points investigators toward finding a genital herpes vaccine that works on both viruses that cause disease. An investigational vaccine protected some women against infection from one of ...

(HealthDay News) – Pritelivir is safe and effective for treatment of genital herpes simplex virus (HSV)-2 infection, according to a study published in the Jan. 16 issue of the New England Journal of ...

Genital herpes is one of the most common types of sexually transmitted infections (STI) in the United States – as well as one of the most frustrating. Characterized by periodic blisters on the ...

Scientific findings establish the effectiveness of Envigo’s new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary ...

Persons who have tested positive for herpes simplex virus type 2 but do not have symptoms or genital lesions still experience virus shedding during subclinical episodes, suggesting a high risk of ...

A new vaccine for genital herpes could be nearing human clinical trials, researchers say. The vaccine has proven effective in animals against herpes simplex virus 2, the sexually transmitted virus ...

The World Health Organization (WHO) recently released new estimates suggesting around 846 million people aged between 15 and 49 live with a genital herpes infection. That’s equivalent to one in every ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio WASHINGTON — The therapeutic vaccine ...

Herpes simplex viruses 1 and 2 are teaming up to ruin your next date. Scientists at the University of Washington School of Medicine have discovered that HSV-1 and 2 — better known as oral and genital ...

The US Preventive Services Task Force (USPSTF) has released new recommendations advising against screening for genital herpes simplex virus (HSV) in asymptomatic adolescents and adults, including ...

Chicago, July 15, 2022 (GLOBE NEWSWIRE) -- According to Arizton’s latest research report, the global genital herpes treatment market is expected to grow at a CAGR of about 3.76%. Around one-third of ...